Healthcare Realty Trust (HR) reported Q2 FFO that beat analyst estimates, but sales, while also beating estimates, showed a year-over-year decline. The mixed results suggest some underlying challenges despite exceeding consensus expectations for the quarter.
Healthcare Realty Trust announced its Q2 earnings, revealing FFO of $0.41 per share, which surpassed the analyst consensus of $0.40. Sales also beat estimates at $281.849 million against $274.580 million. However, the sales figure represents a 5.26% decrease compared to the same period last year, indicating a potential deceleration in revenue growth. This mixed performance suggests that while the company managed to exceed expectations for the quarter, the year-over-year sales decline could be a point of concern for investors. Short-term, the beat on FFO and sales estimates might provide some positive sentiment, but long-term investors will likely scrutinize the revenue trend. Traders might see an opportunity in the short-term positive reaction to the FFO beat, but should be mindful of the underlying sales decline.